Camilla Amaral Ph.D

PhD. Camilla Amaral is an accomplished professional in the agrotech sector, currently serving as CEO at Doroth since January 2020, where expertise in molecular biology techniques such as metagenomics, qPCR, LAMP, and lab-on-a-chip is applied to monitor commercial microorganisms for agriculture. Prior to this role, Camilla founded CFA Scientia and held positions at Neodent as T&E Global Specialist and Medical Marketing Coordinator from September 2017 to January 2020. Educational credentials include a direct doctoral degree from Universidade Estadual de Campinas, complemented by an externship at Harvard Medical School in 2016, and an undergraduate degree in Dentistry from the same university completed in 2010.